No one left behind: the Cystic Fibrosis Trust’s commitment to ‘the 10%’

Following a major step forward in access to Kaftrio, a genotype-specific treatment for cystic fibrosis (CF), the Cystic Fibrosis Trust’s Director of Policy, Programmes, and Support, Dr Keith Brownlee, sets out the Trust’s determination to ensure the best care, treatment and support for everyone with cystic fibrosis.